| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Genomics Research Center, Academia Sinica; 2 Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan
Requests for reprints: Kuo-I Lin, Genomics Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang District, Taipei 115, Taiwan. Phone: 886-2-2789-9930, ext. 336; Fax: 886-2-2789-9931; E-mail: kuoilin{at}gate.sinica.edu.tw.
B lymphocyte–induced maturation protein-1 (Blimp-1) is a transcriptional repressor that plays an important role during plasmacytic differentiation and is expressed in normal and transformed plasma cells. We here investigated the importance of continuous Blimp-1 expression. We found that knockdown of Blimp-1 expression by lentiviral vector-delivered short hairpin RNA causes apoptosis in multiple myeloma cell lines and plasmacytoma cells, indicating that continued expression of Blimp-1 is required for cell survival. We examined the mechanism underlying Blimp-1 knockdown-mediated apoptosis and found that the Blimp-1 knockdown neither reversed the phenotypic markers of plasma cells nor caused cell cycle arrest. Instead, our results show that knockdown of Blimp-1 induced the proapoptotic protein Bim, reduced the antiapoptotic protein Mcl-1, and activated caspase-9 and caspase-3. We further link apoptosis in transformed plasma cells mediated by proteasome inhibitors, the effective therapeutic agent for multiple myeloma patients, with reduced expression of Blimp-1. Lastly, we show that Blimp-1–dependent cell survival may act downstream of IFN regulatory factor 4 (IRF4) because IRF4 knockdown leads to down-regulation of Blimp-1 and apoptosis in multiple myeloma cells and plasmacytoma cells. Together, our data suggest that Blimp-1 ensures the survival of transformed plasma cells. [Cancer Res 2007;67(24):11914–23]
This article has been cited by other articles:
![]() |
Y.-H. Chan, M.-F. Chiang, Y.-C. Tsai, S.-T. Su, M.-H. Chen, M.-S. Hou, and K.-I Lin Absence of the Transcriptional Repressor Blimp-1 in Hematopoietic Lineages Reveals Its Role in Dendritic Cell Homeostatic Development and Function J. Immunol., December 1, 2009; 183(11): 7039 - 7046. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D'Costa, D. Emslie, D. Metcalf, G. K. Smyth, A. Karnowski, A. Kallies, S. L. Nutt, and L. M. Corcoran Blimp1 is limiting for transformation in a mouse plasmacytoma model Blood, June 4, 2009; 113(23): 5911 - 5919. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-T. Su, H.-Y. Ying, Y.-K. Chiu, F.-R. Lin, M.-Y. Chen, and K.-I Lin Involvement of Histone Demethylase LSD1 in Blimp-1-Mediated Gene Repression during Plasma Cell Differentiation Mol. Cell. Biol., March 15, 2009; 29(6): 1421 - 1431. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Tsai, Y.-K. Chiu, T.-L. Hsu, I-Y. Lin, S.-L. Hsieh, and K.-I Lin Galectin-1 Promotes Immunoglobulin Production during Plasma Cell Differentiation J. Immunol., October 1, 2008; 181(7): 4570 - 4579. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |